Literature DB >> 16849765

Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma.

Tsu-Yao Cheng1, Jaw-Town Lin, Li-Tzong Chen, Chia-Tung Shun, Hsiu-Po Wang, Ming-Tsang Lin, Tsang-En Wang, Ann-Lii Cheng, Ming-Shiang Wu.   

Abstract

PURPOSE: Helicobacter pylori infection and host susceptibility interact to develop gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and activation of specific T cells might play a crucial role in this process. Recent investigations show that the CTLA4, CD28, and ICOS genes are located on chromosome 2q33 and their polymorphisms confer susceptibility to infectious and immune diseases through deregulation of T-cell stimulation. We aimed to determine the role of CTLA4, CD28, and ICOS polymorphisms in gastric MALT lymphoma. PATIENTS AND METHODS: Genotyping for CTLA4 (49 A/G, -318 C/T, and CT60 A/G), CD28 (IVS3+ 17T/C), and ICOS (c.602 A/C and c.1624C/T) was performed for 62 patients with gastric MALT lymphoma and compared with 250 unrelated healthy controls.
RESULTS: H pylori infection was significantly higher in patients with gastric MALT lymphoma (90.3%) compared with controls (66.4%; P < .001). The CTLA4 -318 C/T genotype was associated with a lower risk of developing gastric MALT lymphoma (odds ratio [OR] = 0.3; P = .022), whereas CTLA4 49 G/G genotype was linked to a higher risk (OR = 4.1; P = .044). In patients with H pylori infection, CTLA4 49 G/G genotype was associated with an even higher risk (OR = 6.4; P = .047). Carriage of the tightly linked -318C -49G haplotype conferred a four-fold higher susceptibility to MALT lymphoma (OR = 4.2; P = .042). Complete remission after H pylori eradication was related to tumor stage but not to genotypes or haplotypes.
CONCLUSION: These results indicate a genetic link of CTLA4 gene polymorphisms to development of gastric MALT lymphoma and indirectly support the crucial role of host activated T cells in the MALT lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849765     DOI: 10.1200/JCO.2005.05.5434

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  26 in total

Review 1.  Microenvironment abnormalities and lymphomagenesis: Immunological aspects.

Authors:  Joseph G Taylor; John G Gribben
Journal:  Semin Cancer Biol       Date:  2015-07-29       Impact factor: 15.707

2.  Association between the CD28 IVS3 +17T>C (rs3116496) polymorphism and cancer susceptibility: a meta-analysis involving 8,843 subjects.

Authors:  Sheng Zhang; Yafeng Wang; Heping Jiang; Chao Liu; Haiyong Gu; Shuchen Chen; Mingqiang Kang; Weifeng Tang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population.

Authors:  Rajeev Mahajan; Emad M El-Omar; Jolanta Lissowska; Paolo Grillo; Charles S Rabkin; Andrea Baccarelli; Meredith Yeager; Leslie H Sobin; Witold Zatonski; Stephen J Channock; Wong-Ho Chow; Lifang Hou
Journal:  Jpn J Clin Oncol       Date:  2008-08-07       Impact factor: 3.019

4.  Quantitative assessment of the associations between CD28 T > C polymorphism (rs3116496) and cancer risk.

Authors:  Jianjun Cong; Shulong Zhang; Xueren Gao
Journal:  Tumour Biol       Date:  2014-06-14

5.  Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer?

Authors:  Lidia Karabon; K Tupikowski; A Tomkiewicz; A Partyka; E Pawlak-Adamska; A Wojciechowski; A Kolodziej; J Dembowski; R Zdrojowy; I Frydecka
Journal:  Pathol Oncol Res       Date:  2017-01-18       Impact factor: 3.201

6.  CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer.

Authors:  Marleen M Welsh; Katie M Applebaum; Steven K Spencer; Ann E Perry; Margaret R Karagas; Heather H Nelson
Journal:  Cancer Res       Date:  2009-07-21       Impact factor: 12.701

7.  Association between the cytotoxic T-lymphocyte antigen 4-318C/T polymorphism and malignant tumor risk.

Authors:  Taiming Li; Chengdi Wang; Zhenju Ren; Y I Ji; Chang Xu; Bing Xiao; Min Liu
Journal:  Biomed Rep       Date:  2016-05-19

8.  Associations between CTLA-4 +49 A/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control studies.

Authors:  Lu Wang; Zhiwei Jiang; Hao Qiu; Weifeng Tang; Tanghai Duan; Lixin Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

9.  Meta-analysis of the cytotoxic T-lymphocyte antigen 4 gene +6230G/A polymorphism and cancer risk.

Authors:  H-Y Zhao; H-X Duan; Y Gu
Journal:  Clin Transl Oncol       Date:  2014-02-04       Impact factor: 3.405

10.  Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?

Authors:  Marna G Bouwhuis; Andreas Gast; Adina Figl; Alexander M M Eggermont; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Cancer Immunol Immunother       Date:  2010-02       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.